Analytical Data
-
基因名
IGSF6
- Application
-
别名
IGSF6; DORA; Immunoglobulin superfamily member 6; IgSF6; Protein DORA
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95976
-
表达区间
29-241aa
-
氨基酸序列
TLSVTQPWYLEVDYTHEAVTIKCTFSATGCPSEQPTCLWFRYGAHRPENLCLDGCKSEADKFTVREALKENQVSLTVNRVTSNDSAIYICGIAFPSVPEARAKQTGGGTTLVVREIKLLSKELRNFLTALVSLLSVYVTGVCVAFILLSKSKSNPLRNKKIKEDSQKKKSARRIFQEIAQELYHKRHVETNQQSEKDNNTYENRRVLSNYERP
-
分子量
49.17 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human LAMC2 Protein，His
Cat：PA2000-221DB
Recombinant Human HOXB13 Protein，His
Cat：PA1000-1482
Recombinant E.coli proA Protein，His
Cat：PA2000-4303
Recombinant Human IGSF21 Protein，GST
Cat：PA2000-8446
Protein Description
IGSF6 (Immunoglobulin Superfamily Member 6) is a member of the immunoglobulin superfamily, which plays a crucial role in various biological processes, including cell adhesion, immune response, and signal transduction. Research into IGSF6 has gained traction due to its involvement in the modulation of immune functions and its potential implications in autoimmune diseases and cancer. High expression levels of IGSF6 have been observed in certain immune cells, suggesting a regulatory role in lymphocyte activation and differentiation. The recombinant expression of IGSF6 protein allows for the investigation of its functional properties and molecular interactions in vitro, thus facilitating the understanding of its biological significance. Furthermore, the characterization and study of IGSF6 can lead to the identification of novel therapeutic targets for enhancing immune responses or mitigating pathological conditions. As the field of immunotherapy expands, exploring the role of IGSF6 could provide valuable insights into developing strategies for treating immune-related diseases.
